ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
Daiichi Sankyo Company Ltd (PK)

Daiichi Sankyo Company Ltd (PK) (DSNKY)

28.44
-0.35
(-1.22%)
Closed January 24 4:00PM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
28.44
Bid
28.14
Ask
28.64
Volume
187,973
28.23 Day's Range 28.53
25.11 52 Week Range 42.48
Previous Close
28.79
Open
28.28
Last Trade
75
@
28.44
Last Trade Time
Average Volume (3m)
176,414
Financial Volume
$ 5,334,488
VWAP
28.379

DSNKY Latest News

Apple Loses EU Dispute; Google’s $2.7 Billion Fine Upheld; Oracle Shares Surge 9%

Apple (NASDAQ:AAPL) – The European Court of Justice ruled against Apple in a tax case regarding benefits received in Ireland, potentially leading to the recovery of up to $14.4 billion in...

AstraZeneca, Daiichi Sankyo's Enhertu Gets Approval in EU For Lung Cancer Treatment

By Michael Susin AstraZeneca said that its drug Enhertu, which it developed in partnership with Daiichi Sankyo, has been approved in the European Union for the treatment of advanced non-small cell...

Merck, Daiichi Sankyo Ink Commercialization Deal for Up to $22 Billion

By Ben Glickman Merck and Daiichi Sankyo agreed to jointly develop and commercialize three potential cancer treatments in a deal worth up to $22 billion. Merck and Daiichi Sankyo will develop and...

AstraZeneca Says Trial Results For Breast Cancer Drug Were Highly Positive

By Christian Moess Laursen AstraZeneca said trial results for its breast cancer drug Dato-DXd showed significant improvement for the primary end-point of so-called progression-free survival in...

AstraZeneca's Lung-Cancer Treatment Gets Recommended for Approval in the EU

By Christian Moess Laursen AstraZeneca said its lung-cancer drug Enhertu has been recommended for approval in the European Union following positive test results. The Anglo-Swedish pharma giant...

AstraZeneca Says Datopotamab Deruxtecan Combined With Imfinzi Shows High Disease Control Rates

By Anthony O. Goriainoff AstraZeneca and Daiichi Sankyo said that datopotamab deruxtecan, a cancer drug, combined with the Imfinzi cancer treatment--with or without chemotherapy--showed disease...

AstraZeneca Says Datopotamab Deruxtecan Phase 3 Trial Shows Positive Results in Lung Cancer Patients

By Anthony O. Goriainoff AstraZeneca said Monday that its datopotamab deruxtecan treatment showed positive results in patients with advanced non-small cell lung cancer in a clinical Phase 3...

AstraZeneca Cancer Drug Enhertu Shows Clinically Meaningful, Durable Response in Trial

By Elena Vardon AstraZeneca said Monday that the phase II trial for its cancer drug Enhertu showed clinically meaningful and durable responses across patients with HER2-expressing advanced solid...

AstraZeneca Says Enhertu Recommended for EU Approval for Gastric Cancer

By Kyle Morris AstraZeneca PLC said Monday that Enhertu has been recommended for approval in the European Union for patients with gastric cancer. The Anglo-Swedish pharma major said...

AstraZeneca, Daiichi's Enhertu Approved by the FDA for Lung Cancer Treatment

By Michael Susin AstraZeneca PLC and Daiichi Sankyo Co. have said that their antibody drug Enhertu has been approved by the U.S. Food and Drug Administration to treat adult patients with...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
13.2512.901945216425.1929.2525.1937286527.73342898DR
40.280.99431818181828.1629.2525.1121534127.24764233DR
12-4.09-12.573009529732.5333.2125.1117641428.51039671DR
26-9.285-24.612326043737.72542.4825.1111509730.84444315DR
52-1.32-4.4354838709729.7642.4825.1112980731.85812728DR
1565.8926.119733924622.5542.4819.3912817530.1737282DR
260-39.235-57.975618766267.67599.6318.059052230.3827708DR

DSNKY - Frequently Asked Questions (FAQ)

What is the current Daiichi Sankyo (PK) share price?
The current share price of Daiichi Sankyo (PK) is $ 28.44
What is the 1 year trading range for Daiichi Sankyo (PK) share price?
Daiichi Sankyo (PK) has traded in the range of $ 25.11 to $ 42.48 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MITJFMint Corporation (CE)
$ 0.01
(999,900.00%)
1.5k
SPECSpectaire Holdings Inc (CE)
$ 0.001
(99,900.00%)
3.4k
AWINAERWINS Technologies Inc (CE)
$ 0.0003
(29,900.00%)
809
MHPCManufactured Housing Properties Inc (CE)
$ 0.0003
(29,900.00%)
800
GNRSQGreenrose Holding Company Inc (CE)
$ 0.02
(19,900.00%)
10.2k
AAGRAfrican Agriculture Holdings Inc (CE)
$ 0.000001
(-99.99%)
539
PKLBFPerk Labs Inc (CE)
$ 0.000001
(-99.97%)
104.66k
EVRRFMolecule Holdings Inc (CE)
$ 0.000001
(-99.96%)
30.58k
SEELQSeelos Therapeutics Inc (CE)
$ 0.0001
(-99.94%)
284
ELYSElys BMG Group Inc (CE)
$ 0.000001
(-99.75%)
895
HMBLHUMBL Inc (PK)
$ 0.0008
(0.00%)
254.92M
MMEXMMEX Resources Corporation (PK)
$ 0.0001
(0.00%)
205.15M
GTVHGolden Triangle Ventures Inc (PK)
$ 0.0003
(0.00%)
127.06M
RONNRonn Motor Group Inc (PK)
$ 0.0003
(-25.00%)
114.93M
PDGOParadigm Oil and Gas Inc (PK)
$ 0.0001
(0.00%)
111.05M

Discussion

View Full Feed
DruidOracle55 DruidOracle55 6 minutes ago
What is their NET income for 2024? lets see how many people know what they invest in
IQST
Here Today Here Today 8 minutes ago
Seems like someone is attempting to wrestle away control of the company via majority ownership of the shares. That and there is between 12 - 14 % of total OS shorted that is being reported and not including any of the "Dark Pool - Never Covered" Shorted shares.
RNAZ
DruidOracle55 DruidOracle55 8 minutes ago
P&D in action-so predictable.
UMAV
DruidOracle55 DruidOracle55 10 minutes ago
So more BS
AXXA
DruidOracle55 DruidOracle55 12 minutes ago
Jason is just as real as James Bond
AXXA
DruidOracle55 DruidOracle55 12 minutes ago
Who is Jason?
AXXA
joeycav11 joeycav11 18 minutes ago
I think the reason to keep reiterating stock goes to a buck on mhra approval is to condition shareholders to sell if it opens at 2.50 Make them feel like they should consider taking some money off the table.
NWBO
bbotcs bbotcs 24 minutes ago
A third term for President Trump? https://www.yahoo.com/news/tennessee-republican-proposes-amendment-allow-000727320.html
bbotcs bbotcs 27 minutes ago
Gmenfan: That would be great. So would using more ngas!
bbotcs bbotcs 28 minutes ago
lj: oil
Trump wants cheap oil. Heard on TV tonight, right or wrong I don't know, that they would have to get the oil price down to $45 a barrel to force Russia's economy into major trouble. Stranger things have happened.
It is obvious that Trump is seeking cooperation from the Saudi
Investor2014 Investor2014 29 minutes ago
Highly inappropriate, unscientific and unfortunate, but fits the uniformity of the P2b/3 trial population and so for that reason may not be requiring further trials. I can see that would likely also be a fit with much of the poster population.

https://x.com/adamfeuerstein/status/18825
AVXL
TommyJ7651 TommyJ7651 35 minutes ago
I ran some numbers on Duparquet yesterday with all of the new information we have gotten from the drilling and also the current gold price environment. The current PEA is already outdated in the sense that the deposit has grown A LOT and the gold price has risen almost $1000 since then. They calcula
FFMGF
IVRT IVRT 38 minutes ago
You cannot be a stock trader. What do you actually do? You do not take into consideration the words you put to paper? Read what you typed to me. Boy, that is so left field. I have never traded a stock that I did not take a gamble on. The risk reward profile is what I use. Some risks are worth
BMXI
Gitzstv Gitzstv 38 minutes ago
NO DSGT PENNY SCAM AT THE PGA SHOW THIS YEAR BAHAHAHAHAHAHA 

PROBABLY BECAUSE BOB SILZER CAN'T USE IT TO PUMP THE WORTHLESS STOCK ANYMORE

YOU KNOW HE'D BE MILKING EVERY PR POSSIBLE TALKING ABOUT BOGUS DEALS AND CONTRACTS AND PROMISES TO BUY HIS FAKE CARTS AND EVs HAHAHA
DSGT
Nrdc92 Nrdc92 39 minutes ago
I find it amazing that such faith is put in one person/position. No CEO executes on his/her own. They put a strong team in place to execute the CEO's vision. They are supported by a strong board and a talented group of executives and front line employees. You simply can't switch out the CEO and say
LWLG
Gitzstv Gitzstv 45 minutes ago
THAT PENNY SCAMMING FRAUD LOST EVERYTHING LOL LOL LOL LOL REMEMBER WHEN HE BRAGGED ABOUT BUYING MORE AT 2 CENTS AND EVERY TIME IT DROPPED? HE CLAIMED TO HAVE BEEN BUYING ABOVE $1 ALSO HAHAHAHAHAHA AND SAID HE NEVER SOLD 1 SHARE.

I'M SURE HE THINKS BOB IS A GREAT CEO STILL AND IS SAD H
DSGT
IVRT IVRT 50 minutes ago
What's so special about BMXI trading flat? Been doing for months ain't it? That ain't news!
BMXI
nowwhat2 nowwhat2 50 minutes ago
That was a Do Or Die time there.............Elsewhere, we've been watching this thing form.


https://investorshub.advfn.com/uimage/uploads/2025/1/24/pfhrrSOL_1_23_1m_11-m_wild_wedge_ohtl.jpg


The dippings BENEATH the diagonal there.........THEY were the Do
Swammmie1040 Swammmie1040 55 minutes ago
Got a response to my email tonight from FDCT about the acquisitions of alchemy group and alchemy global and here’s their response.
https://stocktwits.com/Swammie/message/601285958
FDCT
QueenVic QueenVic 59 minutes ago
Where's the comma? Oddly has a space between the 2 and 6
FNMA
nickmerck nickmerck 1 hour ago
because RCAT was always going to be an exit vehicle, and he got out at the best time. Others are probably selling into this as well. Just look at the financials: their margins don't increase with increasing revenues, they don't invest into infrastructure (which would explain the former), and their b
RCAT
ORBAPU ORBAPU 1 hour ago
Well they said nothing about IPE that I saw. Pretty thin gruel
AMRN
nowwhat2 nowwhat2 1 hour ago
That was a Do Or Die time there.............Elsewhere, we've been watching this thing form.


https://investorshub.advfn.com/uimage/uploads/2025/1/24/pfhrrSOL_1_23_1m_11-m_wild_wedge_ohtl.jpg


The dippings BENEATH the diagonal there.........THEY were the Do
BTCUSD
lovethatgreen lovethatgreen 1 hour ago
Possibly
But I wouldn't jump so fast that's it s a scam. They show they have someone that worked for the fda overseeing the BTD submission. That in itself is significant as long as they actually submit the application. It appears they are indeed moving that direction.
Also these su
ADHC

Your Recent History

Delayed Upgrade Clock